410
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma

, , , , , , , , , , , , , , , , , , , & show all
Pages 1898-1907 | Received 29 Nov 2012, Accepted 12 Jan 2013, Published online: 18 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Elena Maiolo, Eleonora Alma, Cecilia Napodano, Francesca Gulli, Silvia Bellesi, Annarosa Cuccaro, Krizia Pocino, Francesco D’Alo’, Marco Iachini, Maurizio Martini, Luigi Maria Larocca, Valerio De Stefano, Umberto Basile & Stefan Hohaus. (2020) The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL). Leukemia & Lymphoma 61:5, pages 1133-1139.
Read now
Maria Joao Baptista, Agueda Hernandez-Rodriguez, Eva Martinez-Caceres, Mireia Morgades, Javier Martinez-Picado, Guillem Sirera, Juan-Manuel Sancho, Evarist Feliu, Josep-Maria Ribera & Jose-Tomas Navarro. (2017) Epstein–Barr viral loads and serum free light chains levels are potential follow-up markers of HIV-related lymphomas. Leukemia & Lymphoma 58:1, pages 211-213.
Read now
Matthew J. Maurer. (2013) The potential of serum light chains in diffuse large B-cell lymphoma. Leukemia & Lymphoma 54:9, pages 1857-1858.
Read now

Articles from other publishers (31)

Patricia Johansson, Stefan Alig, Julia Richter, Christine Hanoun, Jan Rekowski, Jan Dürig, Bauke Ylstra, Daphne de Jong, Wolfram Klapper, Ash A. Alizadeh, Ulrich Dührsen & Andreas Hüttmann. (2023) Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma. Annals of Hematology 102:12, pages 3445-3455.
Crossref
Maria Christina Cox, Fabiana Esposito, Massimiliano Postorino, Adriano Venditti & Arianna Di Napoli. (2023) Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review. Cancers 15:18, pages 4440.
Crossref
Cecilia Napodano, Laura Ioannilli, Valerio Basile, Francesca Gulli, Valeria Carnazzo, Stefano Pignalosa, Luigi Di Biase, Erica Cavaleri, Cosimo Racco, Francesco Equitani, Mariapaola Marino & Umberto Basile. (2023) Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma. Journal of Personalized Medicine 13:5, pages 743.
Crossref
M. Christina Cox, Luigi Marcheselli, Giorgia Scafetta, Carlo Visco, Stefan Hohaus, Ombretta Annibali, Gerardo Musuraca, Alberto Fabbri, Maria Cantonetti, Sabrina Pelliccia, Robel Papotti, Luigi Petrucci, Monica Tani, Roberta Battistini, Annalisa Arcari, Stefano Luminari, Gianluca Lopez, Eleonora Alma, Livio Pupo, Giuseppe Carli, Francesco Marchesi, Francesca Re, Stefania Scarpino, Emanuele S. G. D’amore, Luigi M. Larocca, Antonella Bianchi, Giuseppina Pepe, Fiammetta Natalino, Paola Anticoli-Borza, Natalia Cenfra, Alessandro Andriani, Elisabetta Abruzzese, Cristiano Tesei, Lorenzo Leoncini, Silvia Asioli, Luigi Ruco & Arianna Di Napoli. (2022) IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study. Leukemia 36:11, pages 2719-2723.
Crossref
Xinyue Deng, Meilan Zhang, Jianfeng Zhou & Min Xiao. (2022) Next-generation sequencing for MRD monitoring in B-lineage malignancies: from bench to bedside. Experimental Hematology & Oncology 11:1.
Crossref
Wen-Ye Huang & Zhi-Yun Weng. (2022) Occurrence of MYD88L265P and CD79B mutations in diffuse large b cell lymphoma with bone marrow infiltration: A case report. World Journal of Clinical Cases 10:22, pages 7994-8002.
Crossref
Silvia Sánchez‐Ramón, Helen Chapel & Charlotte Cunningham‐Rundles. (2021) On the relevance of immunodeficiency evaluation in haematological cancer. Hematological Oncology 39:5, pages 721-723.
Crossref
Jin Seok Kim, Sung-Soo Yoon, Chang-Ki Min, Je-Jung Lee, Dok Hyun Yoon & Kihyun Kim. (2021) Screening Tests for Early Diagnosis of Multiple Myeloma and Related Plasma Cell Disorders. The Korean Journal of Medicine 96:5, pages 371-381.
Crossref
Umberto Basile, Francesca Gulli, Cecilia Napodano, Krizia Pocino, Valerio Basile, Ramona Marrapodi, Stefania Colantuono, Laura Todi, Mariapaola Marino, Gian Ludovico Rapaccini & Marcella Visentini. (2020) Biomarkers of minimal residual disease in rituximab‐treated patients with mixed cryoglobulinemia. Biotechnology and Applied Biochemistry 68:2, pages 319-329.
Crossref
Jongheon Jung, Hyewon Lee, Ja Yoon Heo, Myung Hee Chang, Eunyoung Lee, Weon Seo Park, Ju-Hyun Park & Hyeon-Seok Eom. (2021) High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma. Scientific Reports 11:1.
Crossref
Cecilia Napodano, Francesca Gulli, Gian Ludovico Rapaccini, Mariapaola Marino & Umberto Basile. 2021. 299 340 .
Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Aris Spathis, Anthi Bouchla, Irene Glezou, Georgia Stavroulaki, Konstantinos Gkontopoulos, Efthymia Bazani, Periklis G. Foukas & Vasiliki Pappa. (2019) Prognostic significance of monoclonal gammopathy in diffuse large B‐cell lymphoma. Hematological Oncology 37:5, pages 634-637.
Crossref
Sydney Dubois, Bruno Tesson, Sylvain Mareschal, Pierre-Julien Viailly, Elodie Bohers, Philippe Ruminy, Pascaline Etancelin, Pauline Peyrouze, Christiane Copie-Bergman, Bettina Fabiani, Tony Petrella, Jean-Philippe Jais, Corinne Haioun, Gilles Salles, Thierry Jo Molina, Karen Leroy, Hervé Tilly & Fabrice Jardin. (2019) Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles. EBioMedicine 48, pages 58-69.
Crossref
R. Borrows, A. Scheer, P. Cockwell, F. Braun, I. Anagnostopoulos, H. Riess, H. Zimmermann & R. U. Trappe. (2019) Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders. Annals of Hematology 98:3, pages 625-632.
Crossref
M. Christina Cox, Arianna Di Napoli, Alberto Fabbri, Emanuele Cencini & Luigi Ruco. (2017) The significance of serum immunoglobulin paraprotein in diffuse large B‐cell lymphoma. British Journal of Haematology 182:5, pages 741-742.
Crossref
Elodie Bohers, Pierre-Julien Viailly, Stéphanie Becker, Vinciane Marchand, Philippe Ruminy, Catherine Maingonnat, Philippe Bertrand, Pascaline Etancelin, Jean-Michel Picquenot, Vincent Camus, Anne-Lise Menard, Emilie Lemasle, Nathalie Contentin, Stéphane Leprêtre, Pascal Lenain, Aspasia Stamatoullas, Hélène Lanic, Julie Libraire, Sandrine Vaudaux, Louis-Ferdinand Pepin, Pierre Vera, Hervé Tilly & Fabrice Jardin. (2018) Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort. Blood Cancer Journal 8:8.
Crossref
Sydney Dubois, Pierre-Julien Viailly, Elodie Bohers, Philippe Bertrand, Philippe Ruminy, Vinciane Marchand, Catherine Maingonnat, Sylvain Mareschal, Jean-Michel Picquenot, Dominique Penther, Jean-Philippe Jais, Bruno Tesson, Pauline Peyrouze, Martin Figeac, Fabienne Desmots, Thierry Fest, Corinne Haioun, Thierry Lamy, Christiane Copie-Bergman, Bettina Fabiani, Richard Delarue, Frédéric Peyrade, Marc André, Nicolas Ketterer, Karen Leroy, Gilles Salles, Thierry J. Molina, Hervé Tilly & Fabrice Jardin. (2017) Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases. Clinical Cancer Research 23:9, pages 2232-2244.
Crossref
Bertrand Coiffier & Clémentine Sarkozy. (2016) Diffuse large B-cell lymphoma: R-CHOP failure—what to do?. Hematology 2016:1, pages 366-378.
Crossref
Linzhu Zhai, Yuanyuan Zhao, Songguo Peng, Ke Zhu, Rongjian Yu, Hailong Chen, Tongyu Lin & Lizhu Lin. (2016) Detection of the value of consecutive serum total light chain (sTLC) in patients diagnosed with diffuse large B cell lymphoma. Annals of Hematology 95:12, pages 1999-2007.
Crossref
O. A. Gavrilina, E. N. Parovichnikova, E. E. Zvonkov, V. V. Troitskaya, S. K. Kravchenko & V. G. Savchenko. (2016) Diffuse large B-cell lymphoma with monoclonal immunoglobulin secretion. Terapevticheskii arkhiv 88:7, pages 56.
Crossref
Patrizia Mondello, Vincenzo Pitini, Valeria Barresi, Elliott Joseph Brea, Cristian Di Mirto, Carmela Arrigo, Salvatore Cuzzocrea & Michael Mian. (2016) Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent. Experimental Hematology & Oncology 5:1.
Crossref
Emmanuel Bachy & Gilles Salles. (2015) Treatment Approach to Newly Diagnosed Diffuse Large B-Cell Lymphoma. Seminars in Hematology 52:2, pages 107-118.
Crossref
M. Christina Cox, Arianna Di Napoli, Stefania Scarpino & Luigi Ruco. (2014) The immunoglobulin isotype matters in diffuse-large-B-cell lymphoma with serum paraproteinaemia. Annals of Hematology 94:4, pages 681-682.
Crossref
Francesco Turturro. (2015) Constitutive NF- κ B Activation Underlines Major Mechanism of Drug Resistance in Relapsed Refractory Diffuse Large B Cell Lymphoma . BioMed Research International 2015, pages 1-5.
Crossref
Thomas E. Witzig, Matthew J. Maurer, Thomas M. Habermann, Brian K. Link, Ivana N.M. Micallef, Grzegorz S. Nowakowski, Stephen M. Ansell, Joseph P. Colgan, David J. Inwards, Luis F. Porrata, Svetomir N. Markovic, Patrick B. Johnston, Yi Lin, Carrie Thompson, Mamta Gupta, Jerry A. Katzmann & James R. Cerhan. (2014) Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma. American Journal of Hematology 89:12, pages 1116-1120.
Crossref
Marina Achenbach, Joerg Thomas Bittenbring, Marita Ziepert, Evi Regitz, German Ott, Andreas Rosenwald, Michael Pfreundschuh, Bettina Altmann & Gerhard Held. (2014) Elevated serum free light chains do not predict outcome of elderly patients with aggressive CD20 + B-cell lymphomas . British Journal of Haematology 167:3, pages 430-434.
Crossref
R. Vaidya & T.E. Witzig. (2014) Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. Annals of Oncology 25:11, pages 2124-2133.
Crossref
Xiaohong Han, Jianfei Wang, Ningning Zhang, Jiarui Yao, Yun Feng, Dan Li, Peng Liu, Jianliang Yang, Shengyu Zhou, Yan Qin, Sheng Yang, Lin Gui, Xiaohui He & Yuankai Shi. (2014) The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphoma. Leukemia Research 38:11, pages 1291-1298.
Crossref
Yu Ri Kim, Soo-Jeong Kim, June-Won Cheong, Yundeok Kim, Ji Eun Jang, Jung Yeon Lee, Yoo Hong Min, Jae-Woo Song, Woo Ick Yang & Jin Seok Kim. (2014) Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classification. Annals of Hematology 93:11, pages 1867-1877.
Crossref
Thomas E. Witzig, Matthew J. Maurer, Mary J. Stenson, Cristine Allmer, William Macon, Brian Link, Jerry A. Katzmann & Mamta Gupta. (2014) Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma. American Journal of Hematology 89:4, pages 417-422.
Crossref
Elodie Bohers, Sylvain Mareschal, Abdelilah Bouzelfen, Vinciane Marchand, Philippe Ruminy, Catherine Maingonnat, Anne-Lise Ménard, Pascaline Etancelin, Philippe Bertrand, Sydney Dubois, Marion Alcantara, Christian Bastard, Hervé Tilly & Fabrice Jardin. (2014) Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma. Genes, Chromosomes and Cancer 53:2, pages 144-153.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.